J. Kemshead

K. Hopkins, J. Kemshead, C. Chandler, 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Meta‐Iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK‐N‐BE(2C)

J. Hancock, J. Kemshead, L. Lashford, 1991, International journal of cancer.

Targeted radiation therapy using monoclonal antibodies: A useful clinical tool?

J. Kemshead, L. Lashford, H. Coakham, 1987 .

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies.

K. Hopkins, J. Kemshead, J. Bullimore, 1998, British Journal of Cancer.

The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescription.

M. Flower, J. Kemshead, D. Ackery, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phenotypic Analysis of Four Human Medulloblastoma Cell Lines and Transplantable Xenografts

J. Trojanowski, D. Bigner, S. Bigner, 1989, Journal of neuropathology and experimental neurology.

Monoclonal Antibodies as Reagents for Brain Tumour Diagnosis: A Review

B. Brownell, J. Kemshead, J. Garson, 1984, Journal of the Royal Society of Medicine.

The use of monoclonal antibodies for the diagnosis of intracranial malignancies and the small round cell tumours of childhood

J. Kemshead, H. Coakham, 1983, The Journal of pathology.

Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues.

B. Bodey, S. Siegel, J. Kemshead, 1996, In vivo.

Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin.

M. Greaves, D. Delia, R. Sutherland, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Removal of malignant cells from bone marrow using magnetic microspheres and monoclonal antibodies.

J. Kemshead, T. Philip, J. Treleaven, 1985, Progress in experimental tumor research.

Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin.

J. Pincott, J. Kemshead, J. Clayton, 1986, British Journal of Cancer.

A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors

H. Coakham, J. Kemshead, L. Lashford, 1988, Cancer.

Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients.

J. Kemshead, H. Coakham, 1998, Journal of neuro-oncology.

Treatment of neoplastic meningitis by targeted radiation using 131I-radiolabelled monoclonal antibodies

H. Coakham, J. Kemshead, 1998, Journal of Neuro-Oncology.

Neoplastic meningitis from a pineal tumour treated by antibody-guided irradiation via the intrathecal route.

R. B. Richardson, H. Coakham, J. Kemshead, 1988, British journal of neurosurgery.

Radioimmunolocalisation of primary cerebral tumours in humans

R. B. Richardson, H. Coakham, J. Kemshead, 1986 .

L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to αvβ3 integrin

P. Altevogt, P. Möller, J. Kemshead, 1996 .

REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERES

J. Kemshead, T. Philip, J. Treleaven, 1984, The Lancet.

Autologous bone marrow transplantation in paediatric solid tumours.

E. Bouffet, J. Kemshead, T. Philip, 1986, Clinics in haematology.

PURGED AUTOLOGOUS BONE MARROW TRANSPLANTATION IN 25 CASES OF VERY POOR PROGNOSIS NEUROBLASTOMA

J. Zucker, M. Favrot, J. Kemshead, 1985, The Lancet.

Monoclonal antibodies and magnetic microspheres used for the depletion of malignant cells from bone marrow.

J. Kemshead, T. Philip, J. Treleaven, 1985, Progress in clinical and biological research.

Novel non-isotopic in situ hybridization technique detects small (1 Kb) unique sequences in routinely G-banded human chromosomes: fine mapping of N-myc and beta-NGF genes.

J. Garson, J. Kemshead, J A Garson, 1987, Nucleic acids research.

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm

F. Walsh, J. Kemshead, K. Patel, 1991, Journal of Neuro-Oncology.

Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over‐expression of the N‐myc oncogene

A. Gown, J. Inazawa, Y. Hayashi, 1990, International journal of cancer.

Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiation.

R. Seeger, J. Kemshead, T. Sawada, 1985, Cancer research.

A monoclonal antibody identifying a cell surface antigen shared by common acute lymphoblastic leukemias and B lineage cells.

M. Greaves, R. Kennett, J. Kemshead, 1980, Blood.

The potential of targeted radiotherapy in the treatment of central nervous system leukaemia.

J. Kemshead, B. Pizer, 1994, Leukemia & lymphoma.

Monoclonal antibodies and magnetic microspheres for the depletion of leukaemic cells from bone marrow harvested for autologous transplantation.

A. Gee, J. Kemshead, J. Treleaven, 1987, Bone marrow transplantation.

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.

J. Kemshead, J. Treleaven, J. Ugelstad, 1986, British Journal of Cancer.

Removal of tumour cells from bone marrow: An evaluation of the available techniques

J. Kemshead, J. Treleaven, J. Treleaven, 1985, Hematological oncology.

Generation of a humanised single chain Fv (Scfv) derived from the monoclonal Eric-1 recognising the human neural cell adhesion molecule.

J. Hancock, J. Kemshead, H. Whittington, 2001, Medical and Pediatric Oncology.

Immunomagnetic colloids for the enrichment of tumor cells from peripheral blood and bone marrow: a model system.

J. Hancock, J. Kemshead, P. Liberti, 1994, Journal of hematotherapy.

A rapid and highly selective approach to cell separations using an immunomagnetic colloid.

J. Hancock, J. Kemshead, J T Kemshead, 1993, Journal of immunological methods.

Neuroblastoma imaged with 123I meta-iodo-benzylguanidine and with 123I-labelled monoclonal antibody, UJ13A, against neural tissue.

S. Mather, J. Kemshead, J. Malpas, 1985, The British journal of radiology.

Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A.

J. Kemshead, G. Vivian, J. Pritchard, 1984, The Journal of pediatrics.

Diagnosis of cerebral neoplasms using monoclonal antibodies.

B. Brownell, J. Kemshead, J. Garson, 1985, Progress in experimental tumor research.

High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.

P. Biron, J. Zucker, M. Favrot, 1987, Medical and pediatric oncology.

Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation.

M. Flower, J. Kemshead, J. Kemshead, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.

H. Hosoi, J. Kemshead, T. Kato, 1988, Cancer research.

MONOCLONAL-ANTIBODIES TO UNCULTURED HUMAN ASTROCYTOMAS

B. Brownell, J. Kemshead, J. Garson, 1982 .

A monoclonal antibody binding to human medulloblastoma cells and to the platelet glycoprotein IIb‐IIIa complex

J. Garson, J. Fritschy, J. Kemshead, 1984, British journal of haematology.

Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166).

J. Kemshead, T. Sawada, M. Okada, 1987, Cancer research.

The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system.

D. Bigner, S. Bigner, J. Schlom, 1987, Acta cytologica.

ANTIBODY-GUIDED RADIATION THERAPY VIA THE CSF FOR MALIGNANT MENINGITIS

R. B. Richardson, H. Coakham, J. Kemshead, 1986, The Lancet.

The use of monoclonal antibodies in the immunohistological diagnosis of cerebral and spinal tumours.

B. Brownell, J. Kemshead, J. Garson, 1984, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

Immunophenotype profile of childhood medulloblastomas and supratentorial primitive neuroectodermal tumors using 16 monoclonal antibodies

B. Bodey, J. Kemshead, A. Marlin, 1990, Cancer.

Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient.

J. Kemshead, T. Sawada, T. Sugimoto, 1986, Cancer research.

The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology

B. Brownell, J. Kemshead, J. Garson, 2005, Journal of Neuro-Oncology.

A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).

M. Flower, J. Kemshead, D. Ackery, 1991, Progress in clinical and biological research.

Forbeck forum on improved drug delivery to brain tumors.

M. Diksic, O. Colvin, J. Kemshead, 1990, Selective cancer therapeutics.

The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.

K. Hopkins, J. Kemshead, V. Papanastassiou, 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Short Communication The treatment of resistant neuroblastoma with 13XI-mlBG: alternative methods of dose prescription

M. Flower, J. Kemshead, D. Ackery, 1992 .

Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.

T. Sugimoto, J. Minowada, A. Green, 1984, Journal of the National Cancer Institute.

diagnosis ofcentral nervous systemtumoursusing amonoclonal antibody panel

J. Garson, H. Coakham, B. Brownell, 1985 .

The Immunomagnetic Manipulation of Bone Marrow

J. Kemshead, 2020 .

The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma

R. Ott, J. Babich, I. Gordon, 2007, European Journal of Nuclear Medicine.

Properties of monoclonal antibodies to nicotinic acetylcholine receptor from chick muscle.

J. Dolly, J. Kemshead, F. Mehraban, 1984, European journal of biochemistry.